Department of Medicine

Medicine & Life Sciences

1. Bone and Bones 100%
2. Osteoporosis 76%
3. Bone Density 74%
4. Calcium 71%
5. Vitamin D 55%
6. Meta-Analysis 40%
7. Therapeutics 38%
8. Placebos 36%
9. Systematic Reviews 34%
10. Postmenopausal Osteoporosis 32%
11. Bone Remodeling 32%
12. Spine 29%
13. Asthma 28%
14. Serum 28%
15. Cancellous Bone 23%
16. Genes 23%
17. Safety 22%
18. Methacholine Chloride 21%
19. Type 2 Diabetes Mellitus 21%
20. Randomized Controlled Trials 20%
21. Confidence Intervals 20%
22. Mortality 19%
23. 25-hydroxyvitamin D 19%
24. Cholecalciferol 19%
25. Osteogenesis 19%
26. Exercise 18%
27. Estrogens 18%
28. Menopause 18%
29. Atrial Fibrillation 18%
30. Teriparatide 18%
31. Databases 18%
32. Lung 18%
33. Elderly 17%
34. Ibandronic Acid 17%
35. Population 17%
36. Cardiac Rehabilitation 16%
37. Biopsy 16%
38. Parathyroid Hormone 15%
39. Skin 15%
40. Quantitative Trait Loci 15%
41. Single Nucleotide Polymorphism 15%
42. Neoplasms 14%
43. Heart Failure 14%
44. Myocardial Infarction 14%
45. Obesity 14%
46. Femur Neck 14%
47. Cortical Bone 13%
48. Incidence 13%
49. Insulin 13%
50. Odds Ratio 13%
51. Metabolic Bone Diseases 13%
52. Minerals 13%
53. Osteoporotic Fractures 13%
54. Calcitriol Receptors 13%
55. Genome 12%
56. Hemorrhage 12%
57. Calcitriol 12%
58. Eosinophils 12%
59. Platelet Activating Factor 12%
60. Inhalation 11%
61. Nutrients 11%
62. Hip 11%
63. Health 11%
64. Pharmaceutical Preparations 11%
65. Femur 11%
66. Glucose 10%
67. Diphosphonates 10%
68. Pedigree 10%
69. Phosphorus 10%
70. Risedronic Acid 10%
71. Histamine 10%
72. Percutaneous Coronary Intervention 10%
73. Guinea Pigs 9%
74. Coronary Artery Disease 9%
75. Hospitalization 9%
76. Nuclear Family 9%
77. Cardiac Arrhythmias 9%
78. Diet 8%
79. Hip Fractures 8%
80. Phenotype 8%
81. Pelvic Bones 8%
82. Conjugated (USP) Estrogens 8%
83. Alendronate 8%
84. Hormones 8%
85. Fats 8%
86. Tibia 8%
87. Biomarkers 8%
88. Survival 8%
89. Hereditary Angioedemas 8%
90. Hereditary Nonpolyposis Colorectal Neoplasms 8%
91. Stroke 8%
92. Immunoglobulin E 7%
93. Veterans 7%
94. Costs and Cost Analysis 7%
95. Thrombosis 7%
96. Equipment and Supplies 7%
97. Coronary Vessels 7%
98. Body Mass Index 7%
99. Drug Therapy 7%
100. Hydroxymethylglutaryl-CoA Reductase Inhibitors 7%